Personal paper - New drug treatment for Alzheimer's disease: lessons for healthcare policy

被引：87

作者：

Melzer, D ^{[1
]}

机构：

[1] Univ Cambridge, Inst Publ Hlth, Dept Community Med, Cambridge CB2 2SR, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7133期

关键词：

D O I：

10.1136/bmj.316.7133.762

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：762 / 764

页数：3

共 20 条

[1] AbelSmith B, 1996, OECD HEAL POL STUD, P17
[2] Policy issues in the private health sector: Examples from long-term care in the U.K.
Bartlett, HP
Phillips, DR
[J]. SOCIAL SCIENCE & MEDICINE, 1996, 43 (05) : 731 - 737
[3] EATON L, 1997, HLTH SERV J, V107, P6
[4] *EIS CORP, 1996, ARICEPT DONEPEZIL LE
[5] FERRIMAN A, 1997, INDEPENDENT 0328, P13
[6] FLETCHER D, 1997, DAILY TELEGRAPH 0405, P9
[7] Advertisements for donepezil (Aricept) in the BMJ - Advertisement suggests an unrealistic improvement in mental status
Gray, S
[J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7093) : 1555 - 1555
[8] IMPALLOMINI M, 1994, LANCET, V334, P1230
[9] Drug treatments for Alzheimer's disease - Raise clinical and ethical problems
Kelly, CA
Harvey, RJ
Cayton, H
[J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7082): : 693 - 694
[10] LAURANCE J, 1997, TIMES 0328, P6